Simvastatin-associated memory loss

Pharmacotherapy

Volumn 21, Issue 6, 2001, Pages 767-769

  Orsi, Amanda ^a   Sherman, Olga ^a,b   Woldeselassie, Zegga ^a  

^a Bronx VA Medical Center ^*  (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN;

ADULT; AMNESIA; ARTICLE; CASE REPORT; DRUG EFFECT; DRUG RESPONSE; DRUG WITHDRAWAL; HUMAN; HYPERCHOLESTEROLEMIA; MALE;

ANTICHOLESTEREMIC AGENTS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MEMORY DISORDERS; MIDDLE AGED; PRAVASTATIN; RECOVERY OF FUNCTION; SIMVASTATIN;

EID: 0034990673     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.21.7.767.34577     Document Type: Article

References (14)

1. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian simvastatin survival study
2. Central nervous system effects of HMG CoA reductase inhibitors: Lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia
3. Effect of statins on risk of coronary disease
4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: Scandinavian simvastatin survival study (4S)
5. Drug treatment of lipid disorders
6. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methyl glutaryl-coenzyme A (HMG-Co A) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin
7. Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers
8. Effect of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia